X4 Pharmaceuticals Cash Flow Statement (2017-2025) | XFOR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-18.68M	-19.64M	-20.18M	-30.21M	-21.96M	-21.21M	-21.59M	-29.10M	-24.02M	-55.71M	-2.31M	-19.13M	-51.77M	90.83M	-36.70M	-39.82M	0.28M	-25.74M	-29.82M	-23.93M
Depreciation and Depletion (Quarter)											0.10M	0.04M	0.06M	0.07M	0.08M	0.09M	0.29M	0.17M
Share-based Compensation (Quarter)	1.26M	1.80M	1.52M	1.61M	1.46M	1.52M	1.11M	1.11M	1.65M	2.14M	2.36M	2.54M	1.74M	2.43M	1.82M	2.22M	0.52M	0.75M	0.76M	2.27M
Gains from Investment Securities (Quarter)	-0.10M	0.10M		1.34M	0.12M	-0.11M			0.05M	24.37M	-24.38M	0.18M	0.12M	0.16M	0.22M	0.14M	0.17M	-0.37M	0.15M	0.20M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-18.44M	-19.20M	-14.21M	-19.05M	-20.23M	-18.47M	-19.31M	-19.09M	-26.51M	-47.90M	-68.80M	-27.75M	-33.60M	-63.90M	-34.03M	-32.99M	-12.40M	-29.90M	-27.79M	-15.51M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.11M	0.13M	0.13M	0.13M	0.13M	0.13M	0.12M	0.12M	0.13M	0.13M	0.10M	0.06M	0.06M	0.19M	0.27M	0.27M	0.48M	0.35M	0.22M	0.22M
Change in Working Capital
Change in Receivables (Quarter)																1.07M	-0.56M	0.64M	-0.25M	-0.32M
Change in Inventory (Quarter)														0.83M	1.61M	0.37M	0.27M	0.08M	0.91M	0.40M
Change in Account Payables (Quarter)	-0.02M	-0.57M	-0.10M	1.86M	-0.71M	0.11M	0.12M	3.91M	-1.71M	-1.10M	3.24M	0.81M	0.00M	-0.95M	0.58M	0.08M	2.48M	-3.44M	-2.65M	0.64M
Change in Accured Expenses (Quarter)	-0.79M	-0.07M	1.92M	-1.22M	-0.98M	1.64M	0.65M	2.50M	0.50M	4.53M	0.63M	-4.04M	1.26M	2.74M	-0.17M	3.34M	-7.78M	0.23M	3.37M	2.17M
Investing Activities
Capital Expenditures (Quarter)	0.50M	0.09M	0.02M	0.01M	0.02M	0.04M	0.01M	0.03M	0.01M	-0.01M	0.03M	-0.03M	0.06M	0.13M	0.09M	0.04M				0.50M
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)											1.00M	1.00M	5.00M	2.00M	5.25M	14.20M	11.75M	28.18M	15.87M	18.75M
Cash from Investing Activities (Quarter)	-0.50M	-0.09M	-0.02M	-0.01M	-0.02M	-0.04M	-0.01M	-0.03M	-0.01M	-4.88M	-5.16M	-4.83M	-5.32M	96.86M	-15.93M	-8.62M	-3.14M	23.11M	-28.67M	16.85M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)											22.50M
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.04M	0.12M		0.10M		0.07M		0.14M			0.00M	0.10M			-0.16M	0.29M			92.44M	146.04M
Shares Repurchased (Quarter)									0.44M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	55.04M	-0.92M	-4.44M	24.57M	4.96M	-0.35M	51.98M	60.64M	-2.12M	69.34M	21.20M	0.10M		20.16M		0.14M		5.63M	86.91M	146.09M
Exchange Rate Effect (Quarter)	-0.14M	0.04M	-0.10M	-0.12M	-0.07M	-0.20M	-0.20M	0.36M	0.05M	-0.01M	-0.07M	0.13M	-0.06M	-0.02M	0.17M	-0.24M	0.07M	0.14M	-0.00M	0.00M
Change in Cash (Quarter)	35.96M	-20.17M	-18.77M	5.39M	-15.36M	-19.06M	32.47M	41.88M	-28.59M	43.02M	-4.85M	-32.36M	-38.98M	86.73M	-49.80M	-41.73M	-15.43M	-1.02M	30.41M	147.42M
Free Cash Flow (Quarter)	-18.94M	-19.28M	-14.23M	-19.07M	-20.25M	-18.51M	-19.32M	-19.13M	-26.52M	-47.89M	-68.83M	-27.72M	-33.66M	-64.03M	-34.12M	-33.04M	-12.40M	-29.90M	-27.79M	-16.01M
Net Cash Flow (Quarter)	36.10M	-20.21M	-18.67M	5.50M	-15.29M	-18.86M	32.66M	41.52M	-28.64M	16.55M	-52.75M	-32.48M	-38.92M	53.12M	-49.96M	-41.48M	-15.54M	-1.16M	30.45M	147.43M

Research Tools

X4 Pharmaceuticals Cash Flow Statement (2017-2025) | XFOR

Create an account

Sign In

Reset Password